Abstract: MicroRNAs (miRNAs) are small non-coding RNAs (ncRNAs) that regulate gene expression. They alter mRNA translation through base-pair complementarity, leading to regulation of genes during both physiological and pathological processes. Viruses have evolved mechanisms to take advantage of the host cells to multiply and/ or persist over the lifetime of the host. Herpesviridae are a large family of double-stranded DNA viruses that are associated with a number of important diseases, including lymphoproliferative diseases. Herpesviruses establish lifelong latent infections through modulation of the interface between the virus and its host. A number of reports have identified miRNAs in a very large number of human and animal herpesviruses suggesting that these short non-coding transcripts could play essential roles in herpesvirus biology. This review will specifically focus on the recent advances on the functions of herpesvirus miRNAs in infection and pathogenesis.
Introduction
MicroRNAs (miRNAs) are single-stranded RNAs of 22-25 nucleotides in length that play important roles in the regulation of gene expression during both physiological and pathological processes. The first cellular miRNAs were identified two decades ago (1) . Since this discovery, the global knowledge regarding the importance of miRNAs has grown exponentially. Cellular miRNAs are known to participate in many biological processes such as cell differentiation, metabolism, homeostasis, apoptosis and cancer. For the last decade, it has also been reported that several viruses also encode and express miRNAs. A general overview of viral miRNAs will be given in this review with an emphasis on the recent findings concerning herpesvirus-encoded miRNAs and their roles during infection and pathogenesis.
General overview of viral miRNAs
Viruses replicating in the nucleus of infected cells benefit from access to the host miRNA generation machinery and are, therefore, more likely to encode miRNAs. In addition, viruses establishing long-term infections often encode viral miRNAs as they provide valuable properties for altering cellular gene expression while remaining invisible for the host immune response (2) . These include DNA viruses such as herpesviruses, polyomaviruses, ascoviruses, baculoviruses, iridoviruses and adenoviruses (3) (4) (5) (6) (7) (8) . However, viral miRNAs are not restricted to DNA viruses and have been found in at least one retrovirus: bovine leukemia virus (BLV) (9) .
The sequences of cellular miRNAs as well as their target mRNA sequence sites are highly conserved, which is suggestive of similar functions (10) . In contrast, although the location of miRNA loci in the genome structure of closely related viruses is generally conserved (11) , there is hardly any conservation of sequence between viral miRNAs (12, 13) . These observations suggest that viral miRNAs have co-evolved with their natural host to become host-specific. Besides the high divergence of sequence between viral miRNAs, some orthologs of cellular host miRNAs have also been described. Viruses use miRNAs as efficient tools to regulate expression of both cellular and viral genes, and viruses have also developed mechanisms to avoid being targeted by cellular miRNAs. Thus, some viruses have evolved strategies to negatively regulate cellular transcripts through mimicking host miRNA functions by providing identical miRNA recognition sequences (14, 15) . The complex interaction between host and viruses involve viral miRNAs which usually favor virus persistence in the infected host through multiple mechanisms, such as inhibiting cell apoptosis, evading the immune response and regulating host and viral genes that often leads to the repression of the viral lytic cycle and promotion of latency (16) .
Viral miRNAs biogenesis
The great majority of viral miRNAs follow a canonical pathway for their biogenesis (17) . In this pathway, miRNAs are initially transcribed by the RNA polymerase II (Pol II) in the nucleus as a long, capped and polyadenylated precursor called primary-miRNA (pri-miRNA). Then, primiRNAs are trimmed into precursor-miRNA hairpin intermediates (pre-miRNAs) by the nuclear RNAse III Drosha. Subsequently, pre-miRNAs are transported in the cytoplasm to be cleaved by the RNAse III Dicer into miRNA duplexes. Duplexes are then separated and one is selected to become the mature single-stranded miRNA whereas the complementary sequence [called the 'star' (*) or 'passenger' miRNA] is normally degraded (18) , although there is some evidence for unique functions and regulatory mechanisms of passenger strands of miRNAs (19) . Following this process, the mature miRNA is incorporated into an effector complex: the RNA-induced silencing complex (RISC).
In addition to the canonical miRNA biogenesis pathway, alternative mechanisms can generate miRNAs or miRNA-like small RNAs (20, 21) . To date, several different non-canonical mechanisms were discovered regarding cellular miRNAs biogenesis (20) . Surprisingly, none of these unusual cellular mechanisms were described for viral miRNAs. In contrast, some viruses seem to have developed Drosha-independent miRNA biogenesis pathways. Two herpesviruses follow the same overall process to generate miRNAs: saimiirine herpesvirus 2 (SaHV-2) and murid herpesvirus 4 (MuHV-4) pre-miRNAs are transcribed as small nuclear RNA (snRNA)-pre-miRNAs and transfer RNA (tRNA)-pre-miRNAs (TMERs) chimeras, respectively (22) (23) (24) . Then, SaHV-2 pre-miRNAs are processed by Integrator whereas MuHV-4 pre-miRNAs are generated by tRNAse Z. In both cases, additional unknown nucleases contribute to the pre-miRNA release. To date, BLV still remains the sole retrovirus-encoding miRNAs. BLV has developed a unique way to generate pre-miRNAs which are processed directly by Pol III into endogenous small hairpin miRNAs (shRNAs) (15) . All viral pre-miRNAs described above follow subsequently the same downstream, mature miRNAs biogenesis, which merge with the canonical pathway.
The RISC-bound miRNA complex can guide the recognition of a sequence in the 3′-untranslated region (3′-UTR) of a target mRNA, which has either extensive or partial complementarity to the miRNA, to induce mRNA cleavage and degradation or mRNA translational inhibition, respectively (25) .
Herpesviruses and miRNAs
The vast majority of viral miRNAs identified so far were reported to be expressed by members of the Herpesviridae family (8, 14, 16, 26) and at least one member of the Alloherpesviridae family (27) . Viral miRNAs were characterized as the most recently discovered weapons in herpesvirus genomes. The majority of miRNAs have been studied in the Herpesviridae family that includes viruses infecting birds and mammals and classified into three subfamilies: alpha-, beta-and gammaherpesvirinae. The first viral miRNAs were found in the Epstein-Barr virus (EBV) genome, a gammaherpesvirus largely infecting humans. EBV miRNAs were identified to be clustered into two distinct regions of the genome: the BamHI fragment H rightward open reading frame 1 (BHRF1) miRNA cluster containing three miRNA precursors and the BamA rightward transcript (BART) miRNA cluster containing 22 miRNA precursors (8, 28) . The distribution of viral miRNAs across the genome can vary from one herpesvirus species to the other. In most gammaherpesviruses, miRNAs are distributed across the genome as clusters (29) whereas miRNAs of cytomegaloviruses are spread across the viral genome (30) .
Recent studies highlighted the increasing complexity in the understanding of viral miRNA functions. For example, miRNAs expressed in both Kaposi's sarcomaassociated herpesvirus (KSHV) and EBV-infected cells were shown to be transferred through exosomes to uninfected recipient cells where they were able to repress the expression of target genes (31, 32) . In addition, a recent study showed that viral miRNAs could be found within EBV virions and might be involved in controlling early steps of infection (33) . Also, a viral miRNA encoded by human cytomegalovirus (hCMV) was shown to unusually target mRNAs 5′-untranslated transcript regions (5′-UTRs) (34) .
In herpesviruses, the viral life cycle has both latent and lytic replication phases, and herpesvirus-encoded miRNAs may be differentially expressed over time. Interestingly, recent studies have shown that herpesviruses can exhibit a distinct pattern of viral miRNAs expression in lytic and latent infection (35, 36) . Within the viral cycle, latent infection is a key feature in herpesvirus biology and is associated with a restricted viral gene expression program that allows viral persistence in infected cells while evading immune surveillance. Among these rare transcripts, non-coding RNAs (ncRNAs), such as miRNAs, were shown to be expressed in latently infected cells, suggesting that viral miRNAs could play an important role in herpesvirus latency (12, 37, 38) . Despite this widespread observation, several studies have reported that herpesvirus-encoded miRNAs could be differentially expressed during latency. Indeed, EBV can exhibit different patterns of latent gene expression depending on the type of infected cells. Most of the time, EBV latency within B cells progresses from latency III to latency II to latency I in contrast to latently infected epithelial cells, such as nasopharyngeal carcinoma (NPC) cells, which can support only the latency II program (39, 40) . Interestingly, the expression of BHRF1 cluster of EBV miRNAs is selectively expressed in B cells undergoing latency III, including lymphoblastoid cell lines (LCLs) and Burkitt's lymphoma (BL) cells (13) . Indeed, the expression of the BHRF1 miRNA cluster was not detected in cells undergoing the EBV latency II or I infection programs. In contrast, the viral BART miRNA cluster is highly expressed in EBV infected cells supporting latency II infection such as NPCs and primary effusion lymphoma (PEL) cells, whereas this miRNA cluster was hardly detectable in LCLs and in most BL cell lines (13) . These observations suggest that herpesvirus-encoded miRNAs could play distinct roles throughout the viral lifecycle in the different infected cell types. The suggestive role played by viral miRNA in herpesvirus latency is furthermore supported by the observation that miRNA genes encoded by alpha-and gammaherpesviruses were found to be clustered within regions of the genome associated with latent gene expression (14) . In KSHV, the 12-identified miRNAs are expressed during viral latency from polycistronic transcripts which also encode the KSHV latent proteins (41) . The accumulated evidence regarding the role played by herpesvirus-encoded miRNAs in regulation of viral latency, cell cycle, lymphomagenesis and immune evasion will be discussed in the present review ( Figure 1 and Table 1 ).
Herpesvirus-encoded miRNAs target viral and cellular transcripts to promote latency
In order to switch from latent to lytic replication, herpesviruses express trans-activating proteins which are able to stimulate the expression of lytic genes (42) (43) (44) (45) . Viral miRNAs encoded by herpesviruses have been demonstrated to promote long-term persistence through restricting the lytic replication program. Indeed, some of these miRNAs are able to target several immediate-early transactivators to lytic replication. Examples include EBV miR BART20-5p (46), ovine herpesvirus 2 (OvHV-2) miR-5 (47), and KSHV miRNAs miR-K1 (48), miR-K9* (49), miR-K5 (50) and miR-K7-5p (51), which have been shown to target reactivation transactivator (RTA) transcripts and thus promote latency. Similarly, herpesvirus simplex 1 (HSV-1) miR-H2 has been shown to target the HSV-1 functional equivalent of RTA, called ICP0, thus preventing reactivation (52) . Likewise gallid herpesvirus 2 (GaHV-2) miR-M7-5p targets the immediate-early genes ICP4 and ICP27 to promote latency in infected chickens (53) . Additional studies have demonstrated that other viral miRNAs were able to target transactivator genes, such as in the case of HSV-2 (54, 55) and hCMV (30) that contribute to the maintenance of latency. However, the relative importance of the miRNA-mediated control of viral reactivation remains to be determined. Interestingly, the lack of viral miRNAs involved in targeting transactivator genes resulted in a small increase of viral reactivation (2-to 3-fold) in contrast to the function of inducers of transactivator transcription (10-to 40-fold). It was therefore suggested that viral miRNAs might act as a "safety mechanism" (49) . Such a mechanism is thought to prevent random variation in the levels of basal transactivator transcripts to fine-tune the control of latency and prevent inappropriate reactivation.
In addition to regulating viral gene expression levels, herpesviruses must control cellular gene expression in order to allow the establishment of long-term latency. Therefore, it is logical to assume that viral miRNAs can target cellular transcripts initially involved in promoting acute replication. However, viral miRNAs may also be involved in modulating cellular expression to create an environment more conducive to reactivation. First, KSHV miR-K1 and miR-K3 both inhibit translation of two cellular nuclear factor kappa B (NF-κB) inhibitors (48, 56) . In fact, the NF-κB signaling pathway was previously reported to play a key role in restricting KSHV acute replication through downregulating RTA expression (57) . Therefore, by targeting NF-κB inhibitors, KSHV viral miRNAs are able to decrease RTA expression levels and promote latency. Furthermore, miR-K3 and miR-K11 were reported to target several cellular transcription factors, which are able to activate RTA, thus indirectly promoting KSHV latency (58) . In addition, a recent study has shown that miR-K3 directly targets G protein-coupled receptor kinase 2 (GRK2) to negatively regulate viral lytic replication through activating C-X-C motif chemokine receptor 2 (CXCR2)/protein kinase B (AkT) signaling (59) . Finally, another study has suggested that several additional KSHV miRNAs, including miR-K5, 9, 10a and 10b, could be involved in sensitizing cells to reactivation stimuli in order to induce KSHV exit of latency (60) . In EBV, mitogen-activated protein kinase kinase kinase 2 (MAP3K2) was shown to be targeted by BART-miR-18-5p (61) . As activation of the MAPK signaling pathway was reported to be required for efficient reactivation (62), BART-miR-18-5p contributes to limit lytic replication in infected cells. Similarly, miR-US25-1-5p encoded by hCMV was shown to target multiple cellular genes to inhibit viral replication (63) . Cdk1, cyclin-dependent kinase 1. BIP, binding immunoglobulin protein. GRK2, G protein-coupled receptor kinase 2; ERAP1b, endoplasmic reticulum aminopeptidase 1b; TWEAKR, TNF-like weak inducer of apoptosis receptor; MYD88, myeloid differentiation primary response 88; IRAK1, interleukin-1 receptor-associated kinase 1; TLR2, Toll-like receptor 2; MICB, MHC class I-related chain B; NFIB, nuclear factor I B; MAP3K2, mitogen-activated protein kinase kinase kinase 2; YWHAE, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon; UBB, polyubiquitin-B precursor; NPM1, nucleophosmin; HSP90AA1, heat-shock protein 90 kDa α family class A member 1; HSV-1, herpesvirus simplex 1 (human herpesvirus 1); EBV, Epstein-Barr virus (human herpesvirus 4); hCMV, human cytomegalovirus (human herpesvirus 5); KSHV, Kaposi sarcoma-associated herpesvirus (human herpesvirus 8); HVS, herpesvirus saimiri (saimiriine herpesvirus 2); OvHV-2, ovine herpesvirus 2; GaHV-2, gallid herpesvirus 2 (Marek's disease virus). herpesvirus miRNAs in restraining reactivation, a recent report has shown that miR-HSUR4-3p present in the herpesvirus saimiri (HVS) U-rich RNAs (HSURs) could repress the expression of the p300 transcriptional coactivator by binding the open reading frame of its mRNA (64) .
Survival and proliferation of latently infected cells and herpesvirus-encoded miRNAs
In addition to restricting the lytic replication program, herpesvirus-encoded miRNAs can also contribute to the survival and proliferation of latently infected cells.
First, HSV-1 miR-H4-5p encoded by latency-associated transcripts (LATs) was shown to promote cell proliferation and invasion in nerve cells by directly targeting a cell cycle inhibitor (65) . Interestingly, HVS miR-HSUR5-3p downregulated WEE1, a negative regulator of cell cycle progression, leading to reduced phosphorylation of its substrate, cyclin-dependent kinase (CDK1) (64) . Furthermore, several studies have shown the potential role of some EBV and hCMV miRNAs in inhibiting cell apoptosis through restriction of expression of pro-apoptotic proteins (66) (67) (68) (69) . Recent in vitro studies highlighted the role of viral miRNAs in EBV-mediated oncogenesis. First, the lack of expression of the BHRF1 miRNA cluster led to reduced transformation capacity and increased apoptosis of primary infected B cells (70, 71) . Similarly, the BART miRNA cluster was shown to promote proliferation of primary infected B cells and inhibit apoptosis in BL cells through targeting caspase-3 (72) . In NPC, EBV miR-BART1 was able to induce metastasis (73) . However, two recent in vivo studies using a humanized mouse model led to contradictory results. First, it was observed that BHRF1 miRNAs contribute to viral growth but did not play a role in EBV-mediated oncogenesis (74) . Furthermore, a second study showed that although the BART miRNA cluster of the EBV M81 strain did not affect the ability of the virus to induce tumors, these viral miRNAs were able to repress B-cell tumorigenesis (75) .
Several KSHV miRNAs were also shown to inhibit cell death by targeting different proteins involved in the induction of apoptosis (48, (76) (77) (78) . Moreover, two recent studies have shown that miR-K3 targets GRK2 to promote endothelial cell migration and angiogenesis and, therefore, could participate to tumor dissemination (59, 79) . In addition, KSHV-encoded miR-K6-3p was lately reported to activate the signal transducer and activator of transcription 3 (STAT3) pathway through directly targeting its inhibitor, the SH3 domain binding glutamate-rich protein (SH3BGR) (80) . This study revealed that miR-K6-3p facilitates endothelial cell migration and angiogenesis leading to the dissemination of KSHV-induced tumors.
The lack of any reliable model for transformation of human cells severely limits the research on KSHVinduced oncogenesis. Nonetheless, a potential role of KSHV miRNAs in promoting cellular transformation using a KSHV-infected rat mesenchymal cell model was recently highlighted (81) . Interestingly, KSHV miR-K11 was reported to share sequence homology with cellular miR-155 (82) . Overexpression of miR-155 is associated with abnormal proliferation of B cells (83) (84) (85) . Thus, miR-K11 could contribute to KSHV-induced cell proliferation by mimicking miR-155 function. Two studies conducted in a humanized mouse model confirmed miR-K11 as a functional ortholog of miR-155, which indicates that miR-K11 might play a key role in the proliferation of KSHV-infected cells (86) (87) (88) . Interesting data on the role of miR-155 orthologs encoded by herpesviruses were reported in chickens infected with GaHV-2, an alphaherpesvirus causing Marek's disease. GaHV-2 encodes two main clusters of viral miRNAs, among which miR-M4 is a functional ortholog of miR-155 that contributes to Marek's disease oncogenesis (89) (90) (91) . Deletion of the miR-155 ortholog miR-M4 of GaHV-2 was sufficient to inhibit the induction of lymphomas in chicken (92) . Importantly, this was the first observation of a direct role of a virus-encoded miRNA in oncogenesis in the context of a natural infection model in vivo. Besides miR-M4, GaHV-2 express another 13 miRNAs, and a recent report by Teng et al. highlighted important roles of miRNAs clustered in the meq oncogene cluster (93) . As such, individual mutants of GaHV-2 miR-M1, -M2, -M3, -M5, or -M9 showed significant attenuation with reduced induction of tumors in infected chicken compared to the virulent strain. Interestingly, GaHV-2 miR-M3 was shown to suppress cisplatin-induced apoptosis through targeting mothers against decapentaplegic homolog 2 (SMAD2) of the transforming growth factor β pathway (94) .
Besides the striking effects of miR-155 orthologs, direct involvement of viral miRNAs has been difficult to demonstrate in vivo. A recent study performed in pigs revealed that deletion of nine of the 11 miRNAs encoded in the large latency transcript of pseudorabies virus (PRV, suid herpesvirus 1) had little effect on latency establishment in the trigeminal ganglia (95) . Recent studies have investigated the potential function of MuHV-4-encoded miRNAs in mice (96) (97) (98) . Using MuHV-4 recombinant strains specifically deficient for the expression of viral miRNAs, the efficiency of B cell infection in vivo was only slightly affected. Moreover, a recent report has highlighted the role of MuHV-4 TMER4 stem-loops in virus dissemination to peripheral sites after intranasal infection, but such reduced dissemination to the spleen was independent of viral miRNAs encoded in TMER4 (98) . These results suggest that ncRNAs, not only miRNAs, play major roles during infection in vivo and highlight the major importance of using genetically engineered recombinant viruses in animal models to address their roles in specific settings. Indeed, while the absence of MuHV-4 miRNAs did not significantly affect the colonization and latency in immunocompetent mice, impairment of MuHV-4 miRNA expression reduced the virulence of MuHV-4 infection in immunocompromised IFN-γ-deficient mice, suggesting a role in promoting gammaherpesvirus-associated disease (96, 97) . In addition, research conducted on malignant catarrhal fever (MCF), a T-cell lymphoproliferative cattle disease induced by OvHV-2 or alcelaphine herpesvirus 1 (AlHV-1) revealed the expression of a very high number of miRNAs after propagation of LCLs and in vivo (73, 74) . However, the deletion from the AlHV-1 genome of 28 clustered-viral miRNAs did not alter the induction of MCF in the rabbit model (99) . These results suggested that AlHV-1 miRNAs are dispensable for lymphoproliferation and MCF lesions. Nonetheless, we could consider their roles in the adaptation of the virus to its natural host, the wildebeest.
Viral miRNAs targeting cellular transcripts to contribute to immune evasion
In order to allow efficient persistent infection, herpesviruses have developed multiple strategies to evade the host immune response, including mechanisms that involve viral miRNAs as effectors.
Several viral miRNAs are able to reduce immune cell recruitment through inhibiting secretion of proinflammatory cytokines. Indeed, hCMV miR-UL112, miR-US5-1 and miR-US5-2 target components of the secretory pathway resulting in decreased release of several proinflammatory cytokines such as tumor necrosis factor (TNF-)α and interleukin (IL-)6 (100). Similarly, KSHV encodes miRNAs that also target genes involved in cytokine secretion. TNF-like weak inducer of apoptosis (TWEAK) is a pro-inflammatory cytokine (101) and its receptor, TWEAKR, was identified as a target of KSHV miR-K10 leading to reduced expression of several proinflammatory cytokines (102) . More recent studies have demonstrated that KSHV miR-K5 and -K9 can also reduce expression of inflammatory cytokines through targeting proteins of the NFκB signaling pathway (48, 56, 103) . Finally, hCMV miR-UL-112-3p was recently shown to downregulate Toll-like receptor 2 (TLR2), thus affecting pathogen recognition (104) .
Viral miRNAs were also shown to counteract cytotoxic T cell and natural killer (NK) cell activation. Indeed, hCMV miR-UL112 has been shown to target MHC class I-related chain B (MICB) which is a stress-induced ligand capable of activating the cytotoxic response of NK cells (105) . Notably, miR-UL112 is able to inhibit MICB expression resulting in a reduced activation of NK cells. As EBV and KSHV were shown to encode miRNAs targeting MICB (106) , this mechanism might be conserved in the Herpesviridae family. In addition, HVS miR-HSUR5-3p could regulate BiP, a chaperone facilitating maturation of MHC class I molecules in the endoplasmic reticulum (64) , and hCMV miR-US4-1 was reported to downregulate antigen loading on MHC class I in infected cells through targeting the endoplasmic reticulum aminopeptidase ERAP1b (107).
Herpesviruses exploit host regulation of viral transcripts and miRNAs to control latency and lytic reactivation
We have focused in this review on herpesvirus-encoded miRNAs and their important functions in the course of viral infection and pathogenesis. However, an increasing body of evidence also highlighted the importance of host miRNAs regulating viral gene transcription and regulation of viral miRNA expression by cellular proteins. Herpesviruses have evolved strategies to turn cellular miRNAs to their advantage to regulate cellular pathways that are critical for virus latency. Examples of such regulatory mechanisms are as follows: In hCMV infected cells, a cellular miRNA family named miR-200 was shown to be involved in maintenance of viral latency through targeting a viral transactivator protein (108) . Moreover, hCMV-infected cells showed a reduction in cellular miR-92a levels leading to an increase of interleukin-10 (IL-10) expression (109) , which was associated with protection from apoptosis and hCMV maintenance of latency. In the case of HSV-1 infected cells, the neuronal-specific miR-138 miRNA was reported to target ICP0, thus promoting latency (110) . In addition, it has been demonstrated that the tumor suppressor protein p53 could control the expression of viral miRNAs from the latency-associated transcript during viral latency and lymphomagenesis (111) , suggesting that virulent viruses also exploit the cellular p53 regulatory network.
Conclusion
The biology of ncRNAs and, in particular viral miRNAs, has gained an increasing interest over the last decade and our knowledge in this field is constantly expanding. Here, we have presented an overview focusing on herpesvirus-encoded miRNAs. To date, only few functions have been uncovered for viral miRNAs in the pathogenesis of herpesvirus-associated diseases. However, a number of recent studies have given much momentum on addressing the functions of viral miRNAs in vivo and have highlighted the importance of complementary genetic recombineering approaches to tackle miRNA functions in a viral context during infection in vivo. Following these tracks, future studies will likely uncover unprecedented functions for viral miRNAs. Whereas cellular miRNAs are highly conserved between species, viral miRNAs seem to be very virus-specific and well-adapted to their natural host. As a result, herpesvirus-encoded miRNAs and associated functions are much likely derived from this co-evolution, which renders the use of natural hosts as in vivo models an inevitable venue for highlighting potential roles in, for example, viral persistence, tumorigenesis and immune evasion. 
